Cytomegalovirus Reactivation Common in COVID-19 Patients
A study indicates that cytomegalovirus (CMV) reactivation is common in COVID-19 ICU patients, especially those on high-dose steroids, and is associated with worse outcomes, suggesting the need for vigilant monitoring and early antiviral intervention.